Factorial Energy Inc. has made a significant move by filing a prospectus supplement that updates its securities offering. This filing is crucial as it reflects the company's ongoing efforts to engage with investors and enhance its position in the market.
Filed on November 10, 2026, the prospectus supplement is part of the company's Registration Statement on Form S-1. It includes details about the sale of 86,441,489 shares of Series A Common Stock by selling securityholders and an additional 13,800,000 shares that can be issued upon the exercise of public warrants.
Factorial Energy, incorporated in Delaware, operates in the miscellaneous electrical machinery, equipment, and supplies sector, as classified under the Standard Industrial Classification (SIC) code 3690. The company trades on the Nasdaq under the ticker symbols FAC and FACWW. It is categorized as an emerging growth company, which allows it to benefit from reduced public company reporting requirements.
The filing indicates the company's commitment to transparency, as it updates the information included in its previous prospectus dated July 7, 2026. This is especially important for investors looking for clarity on the company's financial health and growth prospects.
According to the filing, the last quoted sale price of Factorial's common stock was $4.26 per share, while public warrants were priced at $0.72 each as of November 9, 2026. This pricing information is vital for investors considering their options in the market.
Factorial Energy's recent filings, including a quarterly report on Form 10-Q also filed on November 10, 2026, provide further insights into the company's financial performance and operational updates. The quarterly report is attached to the prospectus supplement, ensuring that investors have access to the latest information.
The impact of this filing may extend beyond just Factorial Energy. As the company continues to navigate its growth in the electrical machinery sector, competitors may need to assess their strategies in response to Factorial's evolving market position.
Looking ahead, the filing does not specify any immediate next steps, but it underscores Factorial's ongoing efforts to maintain investor confidence and transparency in its operations. Investors and market participants will be keen to monitor any further developments from the company.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










